Posted on September 16, 2010 10:20
Categories: Special Populations | Medicare | Treatment and Recovery
Topics: Access/Barriers | Cost-effectiveness | Prescription Drugs | Rates/Reimbursement | Seniors | Spending | Treatment
On August 25, AARP released a report examining retail prices for brand name prescription drugs between 2005 and 2009. The report found that the cost of the most popular drugs rose 41.5 percent over that period, while the Consumer Price Index (CPI) increased by only 13.3 percent. For all 217 drugs studied, AARP found that average annual retail prices increased by 8.3 percent in 2009, 7.9 percent in 2008, 7 percent in 2007, and 6.1 percent in 2006. In addition, all but six of the 217 drugs studied had retail price increases higher than general inflation.
From the report:
2009, using both rolling average and point-to-point estimates (see Appendix A). The first set of findings shows annual rates of change in retail prices for widely used brand name drugs from 2005 through 2009, using both rolling average and point-to-point measures. The rolling average measure also is used to examine the distribution of retail price changes as well as differences in average percentage price changes for individual manufacturers and therapeutic categories. The second set of findings summarizes the cumulative impact of retail drug price changes that have taken place during the five-year period from 2005 through 2009.
Full report: Rx Price Watch Report, August 2010: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Medicare Beneficiaries 2005 to 2009(PDF | 436.87 KB) 
AARP. (2010). Rx price watch report, August 2010: trends in retail prices of brand name prescription drugs widely used by Medicare beneficiaries 2005-2009. Schondelmeyer, S.W. and Purvis, L.
E-mail to Friend |
Print |
Permalink |
Post RSS
